Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| DHR | Danaher Corp. | 0.44% | 161.51 | 0.7% | $722.99m | |
| MDT | Medtronic Plc | 0.25% | 119.13 | 0.6% | $397.75m | |
| ABT | Abbott Laboratories | 0.01% | 88.25 | 0.8% | $359.28m | |
| ISRG | Intuitive Surgical, Inc. | 0.18% | 598.29 | 2.4% | $359.20m | |
| TMO | Thermo Fisher Scientific, Inc. | 0.48% | 336.80 | 1.0% | $306.71m | |
| BDX | Becton, Dickinson & Co. | -0.15% | 276.88 | 1.1% | $261.21m | |
| BSX | Boston Scientific Corp. | 1.48% | 43.20 | 1.1% | $256.43m | |
| SYK | Stryker Corp. | 1.29% | 209.42 | 1.3% | $232.66m | |
| EW | Edwards Lifesciences Corp. | 0.76% | 238.59 | 1.2% | $208.21m | |
| ABMD | ABIOMED, Inc. | 1.98% | 181.44 | 3.3% | $204.09m | |
| BAX | Baxter International, Inc. | 0.49% | 90.00 | 1.8% | $203.74m | |
| ALGN | Align Technology, Inc. | 3.99% | 285.03 | 6.4% | $197.46m | |
| DXCM | DexCom, Inc. | 0.03% | 234.41 | 8.3% | $175.81m | |
| STE | STERIS Plc (Ireland) | 1.08% | 154.21 | 3.7% | $172.62m | |
| NVST | Envista Holdings Corp. | 1.69% | 31.93 | 0.0% | $153.93m |
Company Profile
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.